Home » Topics » BioWorld Science

BioWorld Science
RSS

Glioblastoma stem cells co-opt circadian pacemakers

Sep. 12, 2019

Oryzon Genomics presents preliminary phase II data on iadademstat in SCLC

Sep. 12, 2019

FDA approves Xeris' Gvoke, first ready-to-use stable liquid glucagon for severe hypoglycemia

Sep. 12, 2019

P53 upregulation predicts malaria immunity in children

Sep. 12, 2019

Phio Pharmaceuticals enters agreement with Carisma Therapeutics to enhance adoptive cell therapy

Sep. 12, 2019

KAHR Medical, Roche trial collaboration to test DSP-107/atezolizumab in lung cancer

Sep. 12, 2019

Girafpharma describes cyclin-dependent kinase inhibitors

Sep. 12, 2019

Memorial Sloan-Kettering Cancer Center patents anticancer agents

Sep. 12, 2019

New analgesics synthesized at Daiichi Sankyo

Sep. 12, 2019

Incyte presents new MAP4K1 inhibitors

Sep. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...